Ameriprise Financial, Inc. AMP
Verdict: Sell. Fair value $444 against a price of $494 on 5 Jan 2026, 10% below the price.
In plain words
The case for: Narrow competitive moat provides durability. Market leadership enables pricing power. Industry tailwinds with growing market.
The case against: Intense competitive pressure could compress margins. 2024 Net Income grew 32.8% YoY while Revenue grew only 11.1% YoY, indicating significant margin.... Significant fluctuations in Net Income (2020: $1.53B, 2021: $3.42B, 2023: $2.56B) suggest earnings....
Main risks
- Profitless Growth: Revenue grew 29% since 2021 ($13.38B to $17.26B), yet Net Income is flat/down ($3.42B to $3.40B), indicating significant margin compression.
- Opaque Capital Structure: Missing debt data combined with high Asset-to-Equity ratio (34x) obscures true leverage risk.
- Declining Capital Efficiency: ROIIC is low (2.4%), suggesting recent capital allocation has not generated significant incremental earnings.
- 2024 Net Income grew 32.8% YoY while Revenue grew only 11.1% YoY, indicating significant margin...
- Significant fluctuations in Net Income (2020: $1.53B, 2021: $3.42B, 2023: $2.56B) suggest earnings...
- Intense competitive environment